To induce these feelings of satiety, semaglutide interacts with a region of the brain called the mesolimbic system, which overlaps with brain circuits involved in reward and addiction. This led researchers to hypothesize that GLP-1 mimics drugs like semaglutide and might alter the way our brains respond to addictive substances.